Shopping Cart
The information we provide is for your information only and does not replace a personal consultation, examination or diagnosis by a registered doctor.
In principle, no remote diagnosis or therapy suggestion can be made in individual cases. The information and content provided is intended to offer general, non-binding support to those seeking advice. The information provided by the respective experts is no substitute for a visit to the doctor, but can usefully supplement and support the dialogue between patient and doctor.
We do not offer advice, recommendations or enquiries about the purchase and/or use of medicines, other health products, diagnostic or therapeutic procedures.
We also warn against self-medication. The content provided by us cannot and should not be used to make an independent diagnosis and/or independent selection and application, or to change or discontinue any medication, other health product or healing process. Please consult your doctor or pharmacist for this!
The content available on our website is carefully compiled and meets high quality standards. Medical texts are written by experts. The accuracy of the content is regularly checked and updated. Knowledge in medicine is subject to constant change through scientific research and development in medical practice. Our authors and medical experts ensure that medical information is presented correctly and comprehensibly, even for laypersons. However, we and third parties do not assume any responsibility for the completeness, accuracy, correctness and up-to-dateness of the contents of the website.
PRP in Alzheimer’s, Parkinson’s and ALS: What the Research Really Shows in 2026
Platelet-based preparations are being investigated in cellular and animal models of neurodegenerative diseases. However, PRP, PRGF, platelet lysate, secretome and extracellular vesicles are not the same. This evidence review separates preclinical findings from human data and examines what can actually be concluded for Alzheimer’s, Parkinson’s and ALS as of September 1, 2026.
Read more
PRP Exosomes and Extracellular Vesicles: What the Research Shows
What does science actually tell us about so-called PRP exosomes? This professional article examines platelet-derived extracellular vesicles (EVs), current MISEV2023 terminology, separation and characterization, the available evidence, safety considerations and the regulatory framework. Preclinical findings are clearly distinguished from clinically established applications.
Read more
Long-term storage of PRP: progress, stability and the future of regenerative medicine
How stable is PRP at room temperature, under refrigeration or after freezing? This evidence-based overview examines platelet function, growth factors, sterility, freeze–thaw effects and lyophilisation—and explains why studies do not establish a universal shelf life.
Read more
KIPIC Needles for PRP: Sizes, Selection Criteria and 34G × 8 mm Compared
Which KIPIC needle is suitable for a specific PRP protocol? This guide explains the differences between 25G and 34G needles, compares lengths from 4 to 42 mm and shows why the finest needle is not automatically the best choice. It includes a technical size comparison, information on flow resistance and viscosity, and a dedicated section on the new KIPIC 34G × 8 mm for suitable microinjection techniques.
Read more
Matching PRP Tubes and Centrifuges: Compatibility, Settings and Protocol
Which PRP tubes are compatible with which centrifuge? This article explains RCF, RPM, rotor radius, balancing and documentation using Vi PRP-PRO tubes and the Hettich EBA 200 MD as a reference. Reference setting: 1,200 × g for 7 minutes, equivalent to approximately 3,500 rpm at an 86 mm rotor radius. Current manufacturer instructions and IFUs remain binding.
Read more
PRP Preparation in Hair Medicine: Tubes, RCF and Centrifugation
PRP is not a single standardized preparation. Tube system, anticoagulant, rotor radius, RCF, centrifugation time and cellular composition can influence the resulting PRP. This specialist article explains why PRP studies in hair medicine are only partly comparable, why RCF is more informative than RPM alone and which preparation parameters medical professionals should document.
Read more
PRP for Thin Endometrium: What the Evidence Really Shows in 2026
Can PRP influence endometrial development in women with a thin or refractory endometrium? This article reviews current clinical studies, meta-analyses and assessments by Cochrane, ESHRE and the HFEA, explaining why promising signals have not yet established PRP as a routine treatment.
Read more
Ovarian Insufficiency and PRP Therapy
Intraovarian PRP is being investigated in women with diminished ovarian reserve, poor ovarian response and POI. This evidence review examines current randomized trials, meta-analyses and guidelines, distinguishes POI, DOR and POR, and explains why changes in AMH or AFC should not automatically be equated with improved pregnancy or live-birth outcomes.
Read more
Restoration of tubal function with platelet rich plasma
Can platelet-rich plasma regenerate damaged fallopian tubes or restore their function? We review the 2026 evidence on PRP, hydrosalpinx and tubal infertility and explain why current research does not yet demonstrate clinical effectiveness.
Read more
Dermaroller and its application: synergies with PRP, serums and hyaluronic acid.
Dermaroller is specifically designed to stimulate the natural regeneration of the skin and is increasingly used in combination with other treatments such as PRP, serums and hyaluronic acid.
Read more